Flagship Pioneering as of Sept. 30, 2020
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 8 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 60.3 | $2.2B | 31M | 70.75 | |
| Seres Therapeutics | 16.9 | $611M | 22M | 28.31 | |
| Kaleido Biosciences Ord (KLDO) | 5.9 | $214M | 19M | 11.07 | |
| Denali Therapeutics (DNLI) | 5.9 | $214M | 6.0M | 35.83 | |
| Rubius Therapeutics | 5.3 | $192M | 38M | 5.01 | |
| Evelo Biosciences | 3.3 | $121M | 23M | 5.27 | |
| Axcella Health Inc equity | 1.6 | $58M | 13M | 4.62 | |
| Syros Pharmaceuticals | 0.7 | $26M | 2.9M | 8.84 |
